Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03279939 · ClinicalTrials.gov registry record
Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 88
- Enrollment target
NCT03279939: Completed study, sponsored by Heidelberg Engineering.
NCT03279939 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03279939 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
Assessment of image quality and clinical relevance of OCT Angiography via comparison to FA/ICGA.
Primary Outcome
Image quality grading results of study selected images
Interventions
- DEVICE OCT Angiography
- DEVICE Color Fundus Photography
- DEVICE Fluorescein Angiography
- DEVICE Indocyaine Green Angiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-08-23 |
| Est. Completion | 2018-01-12 |
What the finished NCT03279939 record still lists
NCT03279939 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which OCT Angiography is the first listed.
NCT03279939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03279939 about?
NCT03279939 is a clinical study titled "Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module". Assessment of image quality and clinical relevance of OCT Angiography via comparison to FA/ICGA.
What is the current status of trial NCT03279939?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2017-08-23. Estimated completion is 2018-01-12.
What interventions are being tested in trial NCT03279939?
The interventions under investigation include: OCT Angiography (DEVICE), Color Fundus Photography (DEVICE), Fluorescein Angiography (DEVICE), Indocyaine Green Angiography (DEVICE).
Who is sponsoring clinical trial NCT03279939?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI